Literature DB >> 27284441

Lateral differences in Ki-67 in breast cancer.

Alexey Petrovich Dmitrenko1.   

Abstract

Morphological features of right- and left-sided breast cancer (BC) have been rarely studied. Ki-67 is an independent predictive marker for a local relapse, and for overall and disease-free survival. In previous literature, lateral differences in Ki-67 in BC have not been reported. Using immunohistochemical analysis, the biopsy material of 500 patients was investigated. Four BC parameters were investigated: The expression levels of the estrogen receptor (ER), progesterone receptor (PR), Ki-67 and Her-2-neu. A comparative analysis of Ki-67 in groups with right- and left-sided BC was performed. Lateral differences in Ki-67 in three age groups, ≤49, 50-59 and ≥60 years, were assessed. A higher expression of Ki-67 corresponded with right-sided BC (r=-0.08; P=0.046). Correlation of Ki-67 with the age of the patient was characteristic only for right-sided BC (r=-0.28; P<0.001). The comparative analysis revealed that tumors from patients with right-sided BC aged ≥60 years exhibited a lower Ki-67 index compared with tumors from patients aged ≤49 (P=0.003) and 50-59 years (P=0.000013). In left-sided BC, the Ki-67 in the different age intervals revealed no significant difference. On performing an assessment of lateral differences for the different age intervals, it was established that the Ki-67 index of right-sided BC was significantly higher compared with the left-sided BC in two of the age groups, ≤49 (P=0.038) and 50-59 years (P=0.047). In the ≥60 years group, lateral differences in Ki-67 were not revealed (P=0.4). The analysis of lateral differences in Ki-67 in tumors of various receptor profiles revealed significant differences in Ki-67 of the right- and left-sided BC under ER+ PR- (P=0.007) and ER- PR- (P=0.016) conditions. The reasons behind lateral and age differences of Ki-67 are discussed.

Entities:  

Keywords:  Ki-67; breast cancer; laterality; proliferative activity

Year:  2016        PMID: 27284441      PMCID: PMC4887950          DOI: 10.3892/mco.2016.845

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  24 in total

Review 1.  Hemispheric asymmetry and aging: right hemisphere decline or asymmetry reduction.

Authors:  Florin Dolcos; Heather J Rice; Roberto Cabeza
Journal:  Neurosci Biobehav Rev       Date:  2002-11       Impact factor: 8.989

2.  Structural and functional asymmetry in the human parietal opercular cortex.

Authors:  Patrick Jung; Ulf Baumgärtner; Peter Stoeter; Rolf-Detlef Treede
Journal:  J Neurophysiol       Date:  2009-04-08       Impact factor: 2.714

3.  Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancer.

Authors:  R Ponzone; F Montemurro; F Maggiorotto; C Robba; D Gregori; M E Jacomuzzi; F Kubatzki; D Marenco; A Dominguez; N Biglia; P Sismondi
Journal:  Ann Oncol       Date:  2006-09-15       Impact factor: 32.976

Review 4.  Ki67 in breast cancer: prognostic and predictive potential.

Authors:  Rinat Yerushalmi; Ryan Woods; Peter M Ravdin; Malcolm M Hayes; Karen A Gelmon
Journal:  Lancet Oncol       Date:  2010-02       Impact factor: 41.316

5.  Lower incidence but more aggressive behavior of right sided breast cancer in Pakistani women: does right deserve more respect?

Authors:  Nosheen Fatima; Maseeh Uz Zaman; Aamir Maqbool; Shaista H Khan; Nazia Riaz
Journal:  Asian Pac J Cancer Prev       Date:  2013

6.  [Prevalence of tumors in the left breast].

Authors:  T P Aareleĭd; E K Khint
Journal:  Vopr Onkol       Date:  1987

7.  Association between breast cancer laterality and tumor location, United States, 1994-1998.

Authors:  Carin I Perkins; Joellyn Hotes; Betsy A Kohler; Holly L Howe
Journal:  Cancer Causes Control       Date:  2004-09       Impact factor: 2.506

8.  Breast cancer in Israel: laterality and survival.

Authors:  Y Melnik; P E Slater; R Steinitz; A M Davies
Journal:  J Cancer Res Clin Oncol       Date:  1979       Impact factor: 4.553

9.  Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy.

Authors:  Silvia Darb-Esfahani; Sibylle Loibl; Berit M Müller; Marc Roller; Carsten Denkert; Martina Komor; Karsten Schlüns; Jens Uwe Blohmer; Jan Budczies; Bernd Gerber; Aurelia Noske; Andreas du Bois; Wilko Weichert; Christian Jackisch; Manfred Dietel; Klaus Richter; Manfred Kaufmann; Gunter von Minckwitz
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

10.  Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study.

Authors:  Taghipour Zahir Shokouh; Aalipour Ezatollah; Poorya Barand
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.